Alnylam's Challenge Scaling Up And Moving Beyond The Liver

Alnylam CEO Yvonne Greenstreet talks about what’s next for the company, including a transition into larger therapeutic areas and patient...

Related Keywords

Yvonne Greenstreet ,Alnylam Pharmaceutical ,Ben Comer ,Chief Editor ,Life Science ,